Capstone Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Buy
6,144
+1,363
+29% +$89.6K ﹤0.01% 1337
2026
Q1
$340K Sell
4,781
-6,201
-56% -$489K ﹤0.01% 1313
2025
Q4
$901K Sell
10,982
-3,076
-22% -$240K ﹤0.01% 907
2025
Q3
$1.06M Buy
14,058
+71
+0.5% +$5.3K ﹤0.01% 994
2025
Q2
$1.04M Buy
13,987
+4,715
+51% +$328K ﹤0.01% 842
2025
Q1
$748K Sell
9,272
-5,539
-37% -$476K ﹤0.01% 971
2024
Q4
$1.16M Buy
14,811
+8,555
+137% +$727K ﹤0.01% 1018
2024
Q3
$587K Sell
6,256
-4,178
-40% -$351K ﹤0.01% 1159
2024
Q2
$813K Sell
10,434
-521,051
-98% -$42.5M ﹤0.01% 1069
2024
Q1
$48.3M Buy
531,485
+503,173
+1,777% +$41.9M 0.17% 86
2023
Q4
$2.19M Buy
28,312
+2,938
+12% +$206K 0.01% 772
2023
Q3
$1.73M Buy
+25,374
New +$1.85M 0.01% 780

Other funds holding GEHC

Capstone Investment Advisors's GEHC Position: Q2 2026 in Review

Capstone Investment Advisors increased its GE HealthCare (GEHC) stake by 29% in Q2 2026, buying an estimated $89.6K and bringing the position to 6,144 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

Capstone Investment Advisors first reported a position in GEHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $48.3M in Q1 2024. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Capstone Investment Advisors held 6,144 shares of GE HealthCare worth $393K as of Q2 2026.
  • Capstone Investment Advisors bought 1,363 GE HealthCare shares in Q2 2026, an estimated $89.6K.
  • GE HealthCare made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1337 holding.
  • Capstone Investment Advisors first reported a position in GE HealthCare in Q3 2023 and has held it in 12 quarters since.
  • Capstone Investment Advisors's GE HealthCare position peaked at $48.3M in Q1 2024.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.